Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Collection of Whole Blood Specimens From Pregnant Women at Any Risk of Fetal Chromosomal Anomaly for the Development of a Noninvasive Prenatal Test

NCT03620110 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT03620110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Collection of Whole Blood Specimens From Pregnant Women at Any Risk of Fetal Chromosomal Anomaly for the Development of a Noninvasive Prenatal Test
Lead sponsor
Illumina, Inc.
Phase
Observational
Overall status
Completed
Start date
May 21, 2018
Completion date
December 30, 2019
Enrollment
2,209 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy